Cancer Genomics - Proteomics: 13 (2)

March-April 2016; Volume 13,Issue 2

Open Access
Identification of Prognostically Relevant Chromosomal Abnormalities in Routine Diagnostics of Multiple Myeloma Using Genomic Profiling
EIGIL KJELDSEN

Cancer Genomics & Proteomics March 2016, 13 (2) 91-127;
Open Access
Molecular Basis of Lung Tropism of Metastasis
ULRICH H. WEIDLE, FABIAN BIRZELE, GWENDLYN KOLLMORGEN and RÜDIGER RÜGER

Cancer Genomics & Proteomics March 2016, 13 (2) 129-139;
Open Access
GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification
JI-DUNG LUO, YU-JIA CHANG, CHUNG-MING CHANG, JENG-FU YOU, PO-LI WEI and CHIUAN-CHIAN CHIOU

Cancer Genomics & Proteomics March 2016, 13 (2) 141-150;
Open Access
Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer
XUAN CHEN, YUE LIU, JIAN WU, HUARONG HUANG, ZHIYUN DU, KUN ZHANG, DAIYING ZHOU, KAYLYN HUNG, SUSAN GOODIN and XI ZHENG

Cancer Genomics & Proteomics March 2016, 13 (2) 151-160;
Open Access
Doxorubicin Treatment of Cancer Cells Impairs Reverse Transcription and Affects the Interpretation of RT-qPCR Results
EWA DROZD, JOLANTA KRZYSZTOŃ-RUSSJAN and BEATA GRUBER

Cancer Genomics & Proteomics March 2016, 13 (2) 161-170;
Open Access
Role of BRAF and RAS Mutations in Extrathyroidal Extension in Papillary Thyroid Cancer
JI YEON PARK, JIN WOOK YI, CHAN HEE PARK, YOUNGGYUN LIM, KYE HWA LEE, KYU EUN LEE and JU HAN KIM

Cancer Genomics & Proteomics March 2016, 13 (2) 171-181;

Main menu